EDIT Q2 2020 Earnings — Editas Medicine, Inc. Revenue & Financial Results | Market Cap Arena

EDITEditas Medicine, Inc.

$260M

Q2 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$11M+361.3% YoY

Gross Profit

-$17M-160.6% margin

Operating Income

-$31M-291.6% margin

Net Income

-$24M-219.3% margin

EPS (Diluted)

$-0.43

QoQ Revenue Growth

+87.8%

Cash Flow

Operating Cash Flow

-$31M

Free Cash Flow

-$33M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$655M

Total Liabilities

$229M

Stockholders' Equity

$427M

Cash & Equivalents

$486M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$11M	$2M	+361.3%
Gross Profit	-$17M	-$21M	+18.7%
Operating Income	-$31M	-$36M	+12.1%
Net Income	-$24M	-$34M	+30.2%